Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of Brain in Septic Shock Patients

NCT02706379 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT02706379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02706379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of Brain in Septic Shock Patients
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2015
Completion date
April 30, 2016
Enrollment
26 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock